Epstein-Barr Virus (EBV) Reactivation, Its Treatment with Rituximab and Their Impact on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
Mauricette Michallet(Université Claude Bernard Lyon 1), Franck‐Emmanuel Nicolini(Centre Léon Bérard), Marie Balsat(Hôpital Claude Huriez), Florence Morfin, Fiorenza Barraco(Hôpital Lyon Sud), Catherine Rioufol(Lyon 1 Université), Florence Ader(Université Claude Bernard Lyon 1), Xavier Thomas(Hôpital Lyon Sud), Myriam Renault(Hospices Civils de Lyon), Mohamad Sobh(Ottawa Hospital), Bruno Lina(Hôpital Lyon Sud), Sandrine Leroy(Hôpital Lyon Sud), Caroline Lejeune(Hôpital Lyon Sud), Florence Ranchon(Lyon 1 Université), Hélène Labussière(Hôpital Lyon Sud), Sophie Ducastelle(Hôpital Lyon Sud)
Cited by 4
Related Papers
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547